NU Skin Enterprises Inc (NYSE:NUS)
| 34.56 Delayed Data As of May 26 |  -0.04 / -0.12%Today’s Change | 29.96 Today|||52-Week Range 47.84 | -18.03% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Chang Joseph Y Chief Scientific Officer |  Sale | 3/01/2023 | 68,485 | $40.44 | $2.8M | -15.11% |
Chang Joseph Y Chief Scientific Officer |  Buy | 3/01/2023 | 68,485 | $30.63 | $2.1M | -15.11% |
Lund Steven J Executive Chairman | Sale | 6/13/2022 | 35,573 | $43.75 | $1.6M | -21.06% |
Lawrence Mark H Chief Financial Officer | Sale | 3/02/2023 | 26,144 | $40.80 | $1.1M | -16.00% |
Chang Joseph Y Chief Scientific Officer | Sale | 3/02/2023 | 25,000 | $40.77 | $1.0M | -16.00% |
Napierski Ryan S President & Chief Executive Officer | Sale | 11/25/2022 | 25,000 | $38.45 | $961.3K | -11.05% |
Napierski Ryan S President & Chief Executive Officer | Sale | 2/27/2023 | 21,513 | $41.38 | $890.2K | -16.75% |
Hatchett Steven K Chief Product Officer | Sale | 3/09/2023 | 21,155 | $39.78 | $841.5K | -12.73% |
Chang Joseph Y Chief Scientific Officer | Buy | 3/02/2023 | 24,400 | $30.45 | $743.0K | -16.00% |
Lund Steven J Executive Chairman | Sale | 6/23/2022 | 14,954 | $45.20 | $675.9K | -24.15% |
Page of 7